drugset / Trial / NCT05508815
Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the effectiveness and safety of Modified Zhiwang Decoction in combination with methotrexate for the treatment of early RA patients and a parallel-group, single-center randomized controlled clinical study was designed.
Timeline
- Start
- 2023-02-09
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Modified Zhiwang Decoction | Unknown | 100 ml | — |
| Comparator | Methotrexate | Small molecule | 7.5 mg | — |
| Comparator | Methotrexate | Small molecule | 15 mg | — |